A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma.
Restrepo P, Bhalla S, Ghodke-Puranik Y, Aleman A, Leshchenko V, Melnekoff DT, Agte S, Jiang J, Madduri D, Richter J, Richard S, Chari A, Cho HJ, Jagannath S, Walker CJ, Landesman Y, Laganà A, Parekh S.
Restrepo P, et al. Among authors: richard s.
JCO Precis Oncol. 2022 Jun;6:e2200147. doi: 10.1200/PO.22.00147.
JCO Precis Oncol. 2022.
PMID: 35704796
Free PMC article.